FIELD: biotechnology.
SUBSTANCE: invention represents a vaccine containing an immunogenically effective amount of a protein fragment of the open reading frame 2 of hepatitis E virus (ORF2 HEV), covering from the least region from amino acid 125 to amino acid 607, and to the largest region from amino acid 112 to amino acid 660, and a pharmaceutically acceptable carrier.
EFFECT: invention enables protecting MDA positive pigs against HEV.
9 cl, 2 tbl, 6 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT EXPRESSION OF PROTEIN ORF2 PCV2b IN INSECT CELLS | 2018 |
|
RU2779423C2 |
| NEW HAEMOPHILUS PARASUIS VACCINE | 2020 |
|
RU2822516C1 |
| IMMUNOGENIC COMPOSITIONS FOR IMMUNISING PIGS AGAINST TYPE 3 CIRCOVIRUS AND METHODS FOR PRODUCTION AND APPLICATION THEREOF | 2016 |
|
RU2771533C2 |
| IMMUNOGENIC COMPOSITIONS FOR IMMUNIZATION OF PIGS AGAINST TYPE 3 CIRCOVIRUS AND METHODS OF THEIR PRODUCTION AND USE | 2022 |
|
RU2803427C1 |
| IMMUNOGENIC COMPOSITIONS OF GLYCOPROTEIN G OF HENDRA AND NIPAH VIRUSES | 2012 |
|
RU2787820C2 |
| VACCINES BASED ON VIRUS-LIKE PARTICLES (VLP) OF CANINE PARVOVIRUS (CPV) AND APPLICATION THEREOF | 2016 |
|
RU2710854C1 |
| PORCINE PARVOVIRUS | 2015 |
|
RU2817872C2 |
| PORCINE CIRCOVIRUS TYPE 3 (PCV3) VACCINES, PRODUCTION AND USE THEREOF | 2020 |
|
RU2813989C2 |
| VACCINE TO SWINE INFLUENZA A VIRUS | 2018 |
|
RU2787596C2 |
| VACCINE COMPOSITION AGAINST INFECTION CAUSED BY STREPTOCOCCUS SUIS | 2015 |
|
RU2735101C2 |
